CorMedix Inc. (CRMD) stock
CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.50−0.17 (-3.64%)
Close on Nov 18, 2026Market cap $350.75MP/E –Yield –
CorMedix revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
CorMedix's revenue for the twelve months ending Jun 30, 2026 was $462.25M, up 280.5% year over year. For fiscal 2025 it was $311.71M, up 617.0% from the year before. Over ten years it grew 109.7% a year on average. The highest annual figure on record is $311.71M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $311.71M | +617.0% |
| FY2024 | Dec 31, 2024 | $43.47M | +66362.8% |
| FY2022 | Dec 31, 2022 | $65.41K | -65.7% |
| FY2021 | Dec 31, 2021 | $190.94K | -20.2% |
| FY2020 | Dec 31, 2020 | $239.23K | -15.5% |
| FY2019 | Dec 31, 2019 | $283.27K | -34.1% |
| FY2018 | Dec 31, 2018 | $429.80K | +30.5% |
| FY2017 | Dec 31, 2017 | $329.33K | +47.0% |
| FY2016 | Dec 31, 2016 | $224.11K | +6.7% |
| FY2015 | Dec 31, 2015 | $210.13K | +11.0% |
| FY2014 | Dec 31, 2014 | $189.27K | +9359.0% |
| FY2013 | Dec 31, 2013 | $2.00K | – |
| FY2012 | Dec 31, 2012 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $101.93M | +156.5% |
| Q1 FY2026 | Mar 31, 2026 | $127.43M | +226.1% |
| Q4 FY2025 | Dec 31, 2025 | $128.62M | +312.1% |
| Q3 FY2025 | Sep 30, 2025 | $104.28M | +810.2% |
| Q2 FY2025 | Jun 30, 2025 | $39.74M | +4829.3% |
| Q1 FY2025 | Mar 31, 2025 | $39.08M | +131480.4% |
| Q4 FY2024 | Dec 31, 2024 | $31.21M | +457722.6% |
| Q3 FY2024 | Sep 30, 2024 | $11.46M | +53803.5% |
| Q2 FY2024 | Jun 30, 2024 | $806.12K | +10456.8% |
| Q4 FY2022 | Dec 31, 2022 | $29.70K | -47.3% |
| Q3 FY2022 | Sep 30, 2022 | $6.82K | -82.1% |
| Q2 FY2022 | Jun 30, 2022 | $21.25K | +159.5% |
| Q1 FY2022 | Mar 31, 2022 | $7.64K | -91.3% |
| Q4 FY2021 | Dec 31, 2021 | $56.40K | +1.2% |
| Q3 FY2021 | Sep 30, 2021 | $38.09K | -59.1% |
| Q2 FY2021 | Jun 30, 2021 | $8.19K | -50.2% |
| Q1 FY2021 | Mar 31, 2021 | $88.26K | +19.2% |
| Q4 FY2020 | Dec 31, 2020 | $55.71K | +124.9% |
| Q3 FY2020 | Sep 30, 2020 | $93.02K | +56.3% |
| Q2 FY2020 | Jun 30, 2020 | $16.44K | -53.4% |
| Q1 FY2020 | Mar 31, 2020 | $74.05K | -54.8% |
| Q4 FY2019 | Dec 31, 2019 | $24.78K | -6.6% |
| Q3 FY2019 | Sep 30, 2019 | $59.53K | -84.0% |
| Q2 FY2019 | Jun 30, 2019 | $35.27K | +367.0% |
| Q1 FY2019 | Mar 31, 2019 | $163.69K | +605.3% |
| Q4 FY2018 | Dec 31, 2018 | $26.52K | -71.3% |
| Q3 FY2018 | Sep 30, 2018 | $372.51K | +509.9% |
| Q2 FY2018 | Jun 30, 2018 | $7.55K | -94.5% |
| Q1 FY2018 | Mar 31, 2018 | $23.21K | -41.3% |
| Q4 FY2017 | Dec 31, 2017 | $92.53K | +76367.8% |
| Q3 FY2017 | Sep 30, 2017 | $61.08K | +37.4% |
| Q2 FY2017 | Jun 30, 2017 | $136.17K | – |
| Q1 FY2017 | Mar 31, 2017 | $39.56K | – |
| Q4 FY2016 | Dec 31, 2016 | $121 | – |
| Q3 FY2016 | Sep 30, 2016 | $44.45K | – |
See a number that looks wrong?